BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 20626182)

  • 1. 30 years' experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary.
    Fülöp V; Szigetvári I; Szepesi J; Végh G; Bátorfi J; Nagymányoki Z; Török M; Berkowitz RS
    J Reprod Med; 2010; 55(5-6):253-7. PubMed ID: 20626182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical epidemiology and management of gestational trophoblastic neoplasia in Hungary in the past 34 years.
    Fülöp V; Szigetvári I; Szepesi J; Végh G; Singh M; Berkowitz RS
    J Reprod Med; 2012; 57(7-8):310-8. PubMed ID: 22838247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 25 years' experience in the treatment of gestational trophoblastic neoplasia in Hungary.
    Szigetvári I; Szepesi J; Végh G; Bátorfi J; Arató G; Gáti I; Berkowitz RS; Fülöp V
    J Reprod Med; 2006 Oct; 51(10):841-8. PubMed ID: 17086814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of high-risk metastatic gestational trophoblastic neoplasia in Hungary.
    Fülöp V; Szigetvŕi I; Szepesi J; Török M; Berkowitz RS
    J Reprod Med; 2008 Jul; 53(7):541-6. PubMed ID: 18720931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy.
    Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
    J Reprod Med; 2010; 55(7-8):279-84. PubMed ID: 20795339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience.
    Garrett AP; Garner EO; Goldstein DP; Berkowitz RS
    J Reprod Med; 2002 May; 47(5):355-62. PubMed ID: 12063874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk gestational trophoblastic neoplasia at Gujarat Cancer and Research Institute: thirteen years of experience.
    Chauhan A; Dave K; Desai A; Mankad M; Patel S; Dave P
    J Reprod Med; 2010; 55(7-8):333-40. PubMed ID: 20795348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of primary chemotherapy with single methotrexate on low-risk gestational trophoblastic neoplasia and influencing factors thereof].
    Chen YX; Shen YM; Qian JH; Xie X
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2109-12. PubMed ID: 16313819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of drug resistant gestational trophoblastic neoplasia.
    Patel SM; Desai A
    J Reprod Med; 2010; 55(7-8):296-300. PubMed ID: 20795341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactinomycin and combination regimens.
    Abrão RA; de Andrade JM; Tiezzi DG; Marana HR; Candido dos Reis FJ; Clagnan WS
    Gynecol Oncol; 2008 Jan; 108(1):149-53. PubMed ID: 17931696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of metastatic high-risk gestational trophoblastic neoplasia: FIGO stages II-IV: risk factor score > or = 7.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2010; 55(5-6):199-207. PubMed ID: 20626175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the response to chemotherapy in gestational trophoblastic neoplasia with vaginal metastases.
    Ghaemmaghami F; Behroozi S; Mousavi A; Ashrafgangooei T; Gilani MM; Behtash N; Ghanbari Z
    Arch Gynecol Obstet; 2008 Oct; 278(4):315-8. PubMed ID: 18293004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy regimens used in the treatment of gestational trophoblastic neoplasia at Philippine General Hospital: treatment outcomes and toxicity.
    Cagayan MS; Gacoba MC
    J Reprod Med; 2006 Nov; 51(11):907-18. PubMed ID: 17165439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actinomycin D for methotrexate-failed low-risk gestational trophoblastic neoplasia.
    Lurain JR; Chapman-Davis E; Hoekstra AV; Schink JC
    J Reprod Med; 2012; 57(7-8):283-7. PubMed ID: 22838241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia].
    Jiang J; Nan FF; Yang XS; Zhang YZ; Wang B; Kong BH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):595-9. PubMed ID: 17983513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekly methotrexate (50mg/m(2)) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia.
    Kang WD; Choi HS; Kim SM
    Gynecol Oncol; 2010 Jun; 117(3):477-80. PubMed ID: 20347479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
    Lurain JR; Nejad B
    Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolving role of hysterectomy in gestational trophoblastic neoplasia at the New England Trophoblastic Disease Center.
    Clark RM; Nevadunsky NS; Ghosh S; Goldstein DP; Berkowitz RS
    J Reprod Med; 2010; 55(5-6):194-8. PubMed ID: 20626174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment results of methotrexate and folinic acid as primary chemotherapy for nonmetastatic gestational trophoblastic neoplasia.
    Srisomboon J; Suprasert P; Phongnarisorn C; Charoenkwan K; Siriaree S; Cheewakriangkrai C; Tantipalakorn C; Kietpeerakool C
    J Med Assoc Thai; 2005 Jul; 88(7):886-90. PubMed ID: 16241014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.